Financials Canature Health Technology Co., Ltd.

Equities

300272

CNE1000018L9

Environmental Services & Equipment

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
5.24 CNY +0.96% Intraday chart for Canature Health Technology Co., Ltd. +2.14% -15.48%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,144 2,845 2,948 4,078 2,949 3,483
Enterprise Value (EV) 1 3,102 2,943 3,024 4,110 3,100 3,538
P/E ratio 9.01 x 28.7 x 102 x 39.9 x 32.6 x 26.8 x
Yield 1.52% 2.05% 0.98% 1.39% 1.92% 1.61%
Capitalization / Revenue 3.49 x 2.7 x 2.5 x 2.7 x 1.78 x 2.08 x
EV / Revenue 3.44 x 2.8 x 2.56 x 2.72 x 1.87 x 2.12 x
EV / EBITDA 36.1 x 18.9 x 16.2 x 22.7 x 17.5 x 17.3 x
EV / FCF -6.67 x 28.4 x 109 x 30.7 x 28.9 x 21.3 x
FCF Yield -15% 3.52% 0.92% 3.25% 3.46% 4.68%
Price to Book 2.76 x 2.38 x 2.51 x 3.39 x 2.68 x 2.73 x
Nbr of stocks (in thousands) 573,387 583,018 576,871 567,172 566,100 561,705
Reference price 2 5.483 4.880 5.110 7.190 5.210 6.200
Announcement Date 4/23/19 4/27/20 4/25/21 4/27/22 4/27/23 4/23/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 901 1,053 1,181 1,511 1,661 1,672
EBITDA 1 85.88 155.5 186.5 180.9 177.5 204.6
EBIT 1 54.98 127 151.1 140.4 129 158.8
Operating Margin 6.1% 12.07% 12.79% 9.29% 7.77% 9.5%
Earnings before Tax (EBT) 1 377.3 177.3 66.3 145.5 114.3 158.8
Net income 1 348 100.5 26.42 104.9 92.73 132.4
Net margin 38.62% 9.55% 2.24% 6.94% 5.58% 7.92%
EPS 2 0.6083 0.1700 0.0500 0.1800 0.1600 0.2312
Free Cash Flow 1 -465 103.7 27.78 133.8 107.4 165.7
FCF margin -51.6% 9.85% 2.35% 8.85% 6.47% 9.91%
FCF Conversion (EBITDA) - 66.66% 14.89% 73.95% 60.51% 80.99%
FCF Conversion (Net income) - 103.12% 105.14% 127.55% 115.8% 125.13%
Dividend per Share 2 0.0833 0.1000 0.0500 0.1000 0.1000 0.1000
Announcement Date 4/23/19 4/27/20 4/25/21 4/27/22 4/27/23 4/23/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 97.4 76.2 32.3 151 55.6
Net Cash position 1 42.4 - - - - -
Leverage (Debt/EBITDA) - 0.6266 x 0.4088 x 0.1786 x 0.8509 x 0.2718 x
Free Cash Flow 1 -465 104 27.8 134 107 166
ROE (net income / shareholders' equity) 24% 10% 4.13% 9.49% 8.39% 12.3%
ROA (Net income/ Total Assets) 1.62% 4.42% 4.98% 4.44% 3.63% 3.72%
Assets 1 21,515 2,274 530.3 2,361 2,557 3,559
Book Value Per Share 2 1.990 2.050 2.030 2.120 1.940 2.270
Cash Flow per Share 2 0.2600 0.3500 0.3100 0.5000 0.7400 1.560
Capex 1 41.1 58.9 43.1 44.8 94.6 80.2
Capex / Sales 4.56% 5.59% 3.65% 2.96% 5.7% 4.8%
Announcement Date 4/23/19 4/27/20 4/25/21 4/27/22 4/27/23 4/23/24
1CNY in Million2CNY
Estimates
  1. Stock Market
  2. Equities
  3. 300272 Stock
  4. Financials Canature Health Technology Co., Ltd.